|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 121.40 PLN | -0.16% |
|
+2.53% | -10.87% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Innovations in The Field of Diagnostics and Health Protection | - | 404K | 516K | 131K | 100K | |||||
Total Assets | 52.73M | 346M | 101M | 173M | 196M | |||||
Interest Expense | -2.61M | -743K | -278K | -210K | -196K | |||||
Income Tax Expense | -1K | 69.05M | 129K | 19.98M | 311K | |||||
CAPEX | -4.91M | -155K | -1.93M | -3.24M | -5.31M | |||||
EBT | -11.72M | 395M | -18.66M | 85.4M | -46.05M | |||||
D&A | 414K | 664K | 1.08M | 1.51M | 2.13M | |||||
Operating Income | -10.25M | 393M | -28.68M | 77.05M | -47.28M | |||||
Net Income | -16.64M | 318M | -18.78M | 65.42M | -46.36M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Poland | - | 404K | 516K | 131K | 100K | |||||
Total Assets | 52.73M | 346M | 101M | 173M | 196M | |||||
Interest Expense | -2.61M | -743K | -278K | -210K | -196K | |||||
Income Tax Expense | -1K | 69.05M | 129K | 19.98M | 311K | |||||
D&A | 414K | 664K | 1.08M | 1.51M | 2.13M | |||||
CAPEX | -4.91M | -155K | -1.93M | -3.24M | -5.31M | |||||
Net Income | -16.64M | 318M | -18.78M | 65.42M | -46.36M | |||||
EBT | -11.72M | 395M | -18.66M | 85.4M | -46.05M | |||||
Operating Income | -10.25M | 393M | -28.68M | 77.05M | -47.28M |
- Stock Market
- Stocks
- SCP Stock
- Financials Scope Fluidics S.A.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
